Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › colistin

colistin

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of colistin

3 trials tracked of colistin: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 300 citations.

3Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 2
  1. Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex Completed · 300 cited
  2. Phase 3 A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) Completed · 22 cited
  3. Phase 4 IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Colistin-based inhalation regimens rank highest for clinical response in multidrug-resistant Acinetobacter baumannii pneumonia
Infectious Disease Sys. Review
Colistin-based inhalation regimens rank highest for clinical response in multidrug-resistant Acinetobacter baumannii pneumonia Colistin Inhalation Tops for Drug-Resistant Pneumonia
This network meta-analysis of 1420 patients with multidrug-resistant Acinetobacter baumannii (MDRAB) pneumonia compared colistin, tigecyclin…
For tough pneumonia, inhaled colistin works best, but sulbactam is a good alternative without the toxicity.
Jul 3, 2026
Newer antibiotics reduce nephrotoxicity and improve eradication of carbapenem-resistant gram-negative bacilli versus generic antibiotics in HABP/VABP
Infectious Disease Meta-analysis
Newer antibiotics reduce nephrotoxicity and improve eradication of carbapenem-resistant gram-negative bacilli versus generic antibiotics in HABP/VABP Newer antibiotics no better at preventing pneumonia deaths
This systematic review and meta-analysis evaluated newer antibiotics versus generic antibiotics for hospital-acquired and ventilator-associa…
Newer antibiotics for hospital-acquired pneumonia don't lower death risk more than older generics, but they do spare kidneys.
Jun 3, 2026
Meta-analysis reveals high Salmonella prevalence in Chinese eggs compared to international standards
Infectious Disease Meta-analysis
Meta-analysis reveals high Salmonella prevalence in Chinese eggs compared to international standards Salmonella in Chinese eggs shows higher rates than US and Europe
A meta-analysis of eggs in China shows Salmonella contamination rates are significantly higher than in the United States and Europe. Farm sa…
A review of data from China shows Salmonella contamination in eggs is more common than in the US and Europe, with higher rates on shells tha…
May 16, 2026